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Abstract
Background: Several genome-wide association studies have recently linked a group of single nucleotide polymorphisms in
the 9p21 region with cardiovascular disease. The molecular mechanisms of this link are not fully understood. We
investigated five different expression microarray datasets in order to determine if the genotype had effect on expression of
any gene transcript in aorta, mammary artery, carotid plaque and lymphoblastoid cells.
Methodology/Principal Findings: After multiple testing correction, no genes were found to have relation to the rs2891168
risk genotype, either on a genome-wide scale or on a regional (8 MB) scale. The neighbouring ANRIL gene was found to
have eight novel transcript variants not previously known from literature and these varied by tissue type. We therefore
performed a detailed probe-level analysis and found small stretches of significant relation to genotype but no consistent
associations. In all investigated tissues we found an inverse correlation between ANRIL and the MTAP gene and a positive
correlation between ANRIL and CDKN2A and CDKN2B.
Conclusions/Significance: Investigation of relation of the risk genotype to gene expression is complicated by the transcript
complexity of the locus. With our investigation of a range of relevant tissue we wish to underscore the need for careful
attention to the complexity of the alternative splicing issues in the region and its implications to the design of future gene
expression studies.
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Introduction
Single-nucleotide polymorphisms (SNPs) in the chromosome
9p21 region have recently been associated with cardiovascular
diseases [1–4]. In Caucasian populations, the SNPs in question are
found in a yin-yang pattern spanning 53 kb [5]. The SNPs in this
haplotype block are associated with both myocardial infarction,
abdominal aortic aneurysm and intracranial aneurysm[6]. A
mechanism behind the link between disease and genotype is
actively being sought. Recently it was reported that the expression
of the nearby genes CDKN2A and CDKN2B as well as the non-
coding ANRIL was linked with the risk genotype [7,8]. None of the
SNPs in the haplotype block are in transcribed regions, and so a
change of expression level through altering of a promoter or
enhancer region is indeed a plausible hypothesis.
Herein we present a detailed investigation of the relation
between gene expression and the disease-associated allele at
rs2891168 and other associated genotypes in a selection of relevant
tissues. This SNP is a representative marker for the haplotype
block.
Results
Analysis of Splice Variants of the ANRIL Gene
RT-PCR amplification and sequencing was performed on RNA
from three different cell lines and cDNA libraries in an effort to
explore the different splice variants of the ANRIL gene. A list of the
transcripts detected can be found in table 1. Full length transcripts
of either 3834 or 2659 bases described previously [9] was not
detected in any of the cDNA libraries investigated. However, the
findings show that previously described transcripts [9] and
bioinformatically annotated transcript tracks [10] do not fully
cover the spectrum of alternative splicing found in ANRIL. Figure 1
shows the UCSC gene track as given in the UCSC genome
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gene names given in this annotation, but avoid any assumptions
about the completeness of the annotation.
As with the previously annotated isoforms of the ANRIL gene,
no open reading frames longer than 100 codons were found in the
new transcripts. The longest open reading frame was of codon-
length 86 and was identified in the 1-5-6-7-19-20 transcript. This
length is 16.3% of the transcript length and no homology for the
protein sequence was identified.
Relation between mRNA Expression Level and Risk
Genotype
In the following we define the relation between a SNP and gene
expression levels as the significance of an additive linear model of
the expression with the genotype as effect, encoded as 0 and 2 for
the homozygotes and 1 for the heterozygote.
Five datasets consisting of expression microarray data and
genotypes of one or more of risk SNPs in 9p21 were analysed: two
different gene expression measurements on lymphoblastoid cell
lines [11,12] from the HapMap project [13], carotid plaque tissue
from the BiKE database, and medial aorta and medial mammary
artery tissue from the ASAP database. The data sets investigated
are further detailed in table 2.
Following the hypothesis that the genotype effect of rs2891168
could be observed in trans, ie. in genes not immediately next to
rs2891168, we investigated the genome-wide set of probe sets,
correcting for multiple testing at a false discovery rate of 0.05. No
genes were found to significantly correlate to the genotype in any
of the data sets investigated. Likewise, in a region of 8 MB centred
on rs2891168 we investigated all probe sets and meta probe sets
for relation to genotype. The most significant relation was found in
the ASAP aorta data set. The meta probe set with Affymetrix
transcript cluster ID 3201670 probing a predicted gene located
0.9 MB centromeric to rs2891168 showed a P=1.05610
23
relation to genotype as shown in Figure 2. However, none of the
genes in the region were found to show significant correlation
when correcting for multiple testing using a false discovery
rate of 0.05.
On the hypothesis that rs2891168 would show a cis-effect, we
focused on the genes within 250 KB. As indicated the splice
variants in this region are not fully known for all tissue types. The
regular approach of summarising microarray data into probe set
and meta probe set is therefore difficult to use. Any delineation of
transcripts assumes prior knowledge of transcript structure. Instead
a per- probe approach was used, in which every single 25-
nucleotide probe is separately analysed for relation to the genotype
in question. If consecutive stretches of probes show significant
relation in the same direction using the above mentioned linear
model, the exons in which the probes match are likely to be part of
a transcript that is regulated in relation to the genotype.
Figure 1. Overview of the genes of interest as annotated by the UCSC genome browser. The UCSC Genes track shows gene predictions
based on data from RefSeq, Genbank, CCDS and UniProt, and is shown here to represent the current consensus on annotation. The first three
references to CDKN2BAS corresponds to what is elsewhere refered to as DQ485454, EU741058 and NR_003529. They all represent different forms of
the ANRIL gene, as taken from the literature.
doi:10.1371/journal.pone.0007677.g001
Table 1. Identified transcript variants.
Cell line Variant identified (Exons in ANRIL) GenBank Accesion
HUVECs 1-5-6-20 GQ495918
1-5-6-16-18-19-20 GQ495920
1-5-6-15-16-17-18-19-20 GQ495925
1-5-6-7-13 EU741058
1-5-6-7-10-13 GQ495924
Lung 1-5-6-19-20 GQ495919
1-5-6-7-19-20 GQ495921
1-5-6-7-16-17-18-19-20 GQ495923
Brain 1-5-6-7-16-18-19-20 GQ495922
doi:10.1371/journal.pone.0007677.t001
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stratified by genotype of rs2891168. Black and grey circles around
each of the probe-denoting triplets indicate varying degrees of
significant relations of expression to genotype. The lack of
continuous stretches of significance suggests that no single part
of ANRIL has expression related to rs2891168 in the ASAP
mammary artery data set. Similar investigations were performed
for MTAP, CDKN2A, CDKN2B and ANRIL. Isoforms containing all
UCSC known exons were used as template sequences for the
analysis, and differences should therefore be observable both in
previously identified isoforms (p15
INK4b, p16
INK4a, ARF etc.) as
well as in hitherto unidentified splice variants.
Using this fine grained analysis model all data sets specified in
table 2 were investigated. The full result is included as
supplementary files S1, S2, S3, S4, and S5. The longest continuous
stretch of significant probes was in the CDKN2A gene, in a region
in the exon 2 to 3 junction of the CDKN2A variant known as
uc003zpj.1 in the UCSC genome browser. This was found in the
lymphoblastoid cell line of the GSE9372 data set and is shown in
Figure 3B. Eight of nine probes in the region show a trend of
relation to rs2891168, five probes at P,0.05. The GSE7851 data
set, which measures another growth of the HapMap lymphoblas-
toid cell lines, did not show this relation. In the BiKE database the
investigation was also performed using only samples from the two
main complementary haplotypes previously described [5]. Results
were largely similar to findings when only the rs2891168 was
investigated, so haplotype analysis was not further pursued.
Co-Expression Studies. All pair wise combinations of genes
in an 8 MB region centred on rs2891168 were investigated for
correlation of expression levels. This was done to determine if
longer range interactions between genes was in effect, in particular
for pairings with one of the genes localised close to rs2891168. The
strongest long-distance correlation found was between MTAP and
a gene DENND4C found 2.7 MB telomeric to rs2891168. This
pair showed a Pearson correlation coefficient of 0.847 in the ASAP
AMed data and 0.810 in the ASAP MMed data set. These
correlations had P,10
216, which was significant after correcting
for multiple testing on 1596 pairings. There was no correlation
between the previously discussed predicted gene with Affymetrix
ID 3201670 and any of the genes in the immediate vicinity of
rs2891168. Supplementary file S6 shows a complete overview of
coexpression in the region.
In the region of MTAP, CDKN2A, CDKN2B and ANRIL co-
expression was investigated using probe-level visualization tools
from GeneRegionScan [14]. This allows analysis of all possible
probe pair combinations within a given local region, thereby
avoiding the problem of strictly defining transcript structure. A
striking feature in all of the data sets analysed is that MTAP
expression, especially the seven exons most 59, shows inverse
correlation with ANRIL, CDKN2A, and in particular CDKN2B
expression. The positive correlation between CDKN2A, CDKN2B
and ANRIL that has previously been reported [9], was also found
in the data sets under investigation here. To what degree depends
on the data set, with the clearest effect seen in the ASAP aorta data
set as shown in Figure 4.
While not generally used as quality control measure in microarray
analysis, the correlation of the intensity of probes within the same
exon can be used to estimate noise levels. Without any noise in the
measurement it would be expected that these probes show perfect
correlation.Followingthis,itshouldbenotedthatsomeoftheprobes
with low expression, show close to no correlation with neighbouring
probes, particularly in the ANRIL region. The low expression of
ANRIL places itcloseto the detection limit.Somedegree ofdetection
power does remain because we accurately detect changes from the
rs10965215 SNP, a SNP that is found in the middle of the first probe
ofexon 2.This SNP is linked with rs2891168 (D9=0.603,R
2=0.34)
in the CEU population [15], and will affect the hybridization
efficiencyoftheprobebecause of the sequence change. Thisisinfact
observed in the CEU population data sets, and we conclude that the
Table 2. Overview of investigated data sets.
Name Tissue Sample number and origin Expression array type Rs2891168 AA/AG/GG
S1 GSE9372 from hapmap cell lines Lympoblastoid cell lines 57 CEU samples in triplicates Affymetrix Human Exon 1.0 ST 39/93/36
S2 GSE7851 from hapmap cell lines Lympoblastoid cell lines 87 CEU and 89 YRI samples Affymetrix Human Exon 1.0 ST 20/48/19
S3 BiKE database Carotid plaque tissue from
endarcteromies
117 Swedish samples Affymetrix HG-U133 plus 2.0 31/44/15
S4 ASAP MMed database Medial mammary artery tissue 88 Swedish samples Affymetrix Human Exon 1.0 ST 29/44/15
S5 ASAP AMed database Medial aorta tissue 89 Swedish samples Affymetrix Human Exon 1.0 ST 32/41/15
doi:10.1371/journal.pone.0007677.t002
Figure 2. Expression plot of meta probe set 3201670 varying
with rs2891168 in the ASAP AMed. Illustration of a relation
between genotype and expression. The plot shows the meta probe set
with Affymetrix transcript cluster ID 3201670. This probe set probes a
predicted gene located 0.9 MB centromeric to rs2891168. The P-value
of this relation is 1.05610
23. Wen taking into account that 614 meta
probe sets in the region were tested, however, this is not significant at a
false discovery rate of 0.05.
doi:10.1371/journal.pone.0007677.g002
9p21 CAD SNP & Gene Expression
PLoS ONE | www.plosone.org 3 November 2009 | Volume 4 | Issue 11 | e7677microarray measurements have at least some degree of detection
power at the expression levels of ANRIL.
Discussion
Recent studies have searched for links between the genotypes
from the described yin-yang haplotype block and expression levels
of nearby genes. At the time of publication, these were the studies
by Jarinova et al. [8] and Liu et al. [7].
One finding of the Jarinova et al. study is that the risk allele is
linked to expression levels of ANRIL in whole blood cells from
healthy human subjects. The direction of this regulation is
dependent on which transcript variant is measured [8]. The Liu
et al. study suggests that the risk allele is linked to decreased
expression of CDKN2A, CDKN2B and ANRIL in peripheral blood
T-cells. This was identified in T-cells from 170 healthy donors. It is
not known in which exons these expression measurements are
performed [7].
The rs10757278 SNP investigated in the Liu et al. study and the
rs1333045 SNP investigated in the Jarinova et al. study are both
found in the same haplotype block as the rs2891168 SNPs, with
which they are in strong LD (r
2=0.894 and r
2=0.746) in the
Figure 3. Detailed analysis of ANRIL in aorta tissue and CDKN2A in lymphoblastoid cell lines. The x-axis denotes the mRNA position in bp
of the gene investigated. Exon structure of the gene is shown immediately above the axis. The y-axis shows the hybridization intensity of probes on
an arbitrary scale. Each triplet of dots indicates a probe, stratified by rs2891168 genotype. Grey circles denote relation to genotype under a linear
additive model at P,0.2. Black circles show relation at P,0.05. A) ANRIL gene with UCSC accession uc003zpm.1 in the ASAP mammary artery data set.
For each probe, the median of 29 AA samples are shown as blue dots, the median of 44 AG samples are shown as purple, and 15 GG samples are
shown as red. B) CDKN2A gene with UCSC accession uc003zpj.1 with expression data from the GSE9372 lymphoblastoid HapMap cell line data set. For
each probe the median expression of 36 biological samples with the AA genotype are shown as blue, 93 AG samples as purple, and 36 GG samples in
red. Samples are from triplicate growths from the same individual, and therefore represent 12, 31, and 12 different individuals. Many probes around
the exon 2 and 3 boundary are found to have p-values below 0.03. The same trend is seen when summarising triplicate values as mean, and
investigating per individual. These figures are available as zoomable pdf-files in supplementary material S4 and S1. Biobank materials were extracted
after informed consent from all participants were obtained, according to the declaration of Helsinki and approved by the ethical committee of the
Karolinska Institute, journal numbers 02-147 and 2006/784-31/1.
doi:10.1371/journal.pone.0007677.g003
Figure 4. Co-expression of ANRIL, CDKN2A, CDKN2B, and MTAP in aorta tissue. Correlation between all pairwise combinations of microarray
probes in ANRIL, CDKN2A, CDKN2B, and MTAP. Dots at the intersection between two probes indicate correlation, in the same style as a Haploview plot.
The colour and the size of each dot are dependent on the Pearson correlation coefficient, with the colour-scale on the bottom of the figure giving the
values. For each gene, the X-axis gives the location of a given probe in the mRNA in nucleotides. See reference [14] for further explanation. Data is
taken from the ASAP aorta database, but the trend that MTAP shows inverse correlation with the three other genes is general for all data sets.
Likewise, some degree of positive correlation between ANRIL, CDKN2A and CDKN2B is observed in all data sets.
doi:10.1371/journal.pone.0007677.g004
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were seen neither in lymphoblastoid cell lines from 87 healthy
CEU individuals nor in carotid plaque tissue from 117 patients
undergoing endarcteromy and in aorta and mammary artery
tissue from 89 patients undergoing treatment for valve disease. On
the contrary, one of the HapMap data sets, the GSE9372 set,
revealed some degree of relation between increased expression of
CDKN2A and the risk allele of the rs2891168.
One possible reason for this contradiction is the size of the data
sets. It is possible that this investigation does not have the power to
identify the associations found. However, in four different data sets
of approximately half the size of the sets presented by Liu et al.[7],
no trends supporting a general expression decrease were observed.
The sample size of Jarinova et al. [8] is comparable to this study.
Another reason could be the different tissue types investigated.
Liu et al. investigates T-cells and Jarinova et al. investigates whole
blood cell. It is possible that gene expression changes are only
observed in immune cells, and that immune cells are central to the
mechanisms of cardiovascular disease affected by rs2891168 and
its linkage block. Indeed, the inflammatory response system is
known to play a central role in central aspects of cardiovascular
pathogenesis. However, the block has been linked to other disease
patterns that are thought to be independent of immune response,
in particular intracranial aneurysm [6]. In light of this we would
expect the effect of the genotype to be found in tissue types that are
implicated in all disease processes to which it has been linked.
One major issue that is likely to be central is that alternative
splicing events are masking reported results. We found splicing
events in ANRIL to be more extensive than previously reported.
We identified 8 new ANRIL splice variants but did not detect the
short and long form splice variants. While this is not certain to
cover the full spectrum of all possible splice variants in all tissues, it
highlights the fact that more extensive alternative splicing does
take place and will affect conclusions made without knowledge of
isoform architecture. The original description of ANRIL reported
the short and long splice variants (2659 and 3834 bp respectively)
in normal human testis mRNA. In the same report, ANRIL
expression in a range of other tissues was detected using PCR with
primers specific to exons 14–16. It is possible therefore that the
expression of the previously annotated short and long form is tissue
specific [9]. Thus, any expression analysis of ANRIL that is
dependent on the presence of specific transcript variants should
undertake a systematic survey of the alternative splice variants
present in each sample type.
We present these results to underscore the fact that the region
surrounding rs2891168 and its linkage block has a complex
pattern of variable splicing and expression change, and that any
conclusions should be made cautiously. It is important to
emphasize that future studies investigating expression of ANRIL
should take into account the presence of multiple transcript
variants that may also vary between different tissue types.
Materials and Methods
Ethics Statement
Biobank materials were extracted after informed consent from
all participants were obtained according to the declaration of
Helsinki and approved by the ethical committee of the Karolinska
Institute, journal numbers 02-147 and 2006/784-31/1.
Sample Collection
The ASAP study included patients undergoing heart-valve
surgery at Karolinska University Hospital, Stockholm, Sweden.
Biopsies were obtained at surgery from dilated and non-dilated
ascending aorta and from mammary artery. The medial layer was
isolated by adventicectomy, incubated with RNAlater (Ambion)
and homogenized with a FastPrep (Qbiogene, Irvine, CA) using
Lysing Matrix D tubes (Invitro cat.no. 6913-100). The BiKE study
included atherosclerotic tissue collected from patients undergoing
carotid endarterectomy at Karolinska University Hospital, Stock-
holm, Sweden. For both biobanks, total RNA was isolated using
Trizol (BRL-Life Technologies) and RNeasy Mini kit (Qiagen) as a
cleanup including treatment with RNase-free DNase set (Qiagen)
according the manufacturer’s instructions. The quality of RNA
was analyzed with an Agilent 2100 bioanalyzer (Agilent Technol-
ogies Inc., Paolo Alto, CA, USA) and quantity was measured by a
NanoDrop (Thermo Scientific).
PCR Analysis of Splice Variants
A forward primer annealing on ANRIL exon 1 found in all
described alternative transcripts (Exon1F ctcgtcgaaagtcttccattct)
and reverse primers annealing on exon 13 of the shorter transcript
(Exon13R caagatagagaagcaggtatc) and exon 19 of the longer
transcript (Exon19R atacagaaagatgaaaagtgatttgcc) were employed
to amplify full length transcripts as described [9]. The Exon13R
primer was used only in the analysis of HUVEC cells. PCR
included 35 cycles of a denaturation step for 15 sec followed by
annealing at 55uC for 15 seconds and a polymerase extension
step of 72uC for 3 minutes. PCR products were run on 1% agarose
gel and products extracted using the QIAquick gel extraction
kit (Qiagen). Purified products were sequenced by capillary
sequencing.
Expression Microarray Processing
The BiKE and ASAP RNA samples were hybridized and
scanned on the Karolinska Institute microarray core facility. For
samples from the BiKE biobank Affymetrix HG-U133 plus 2.0
arrays and protocols were used, whereas Affymetrix GeneChipH
Human Exon 1.0 ST arrays and protocols were used for samples
from the ASAP biobank. Cel files from the GSE9372 and
GSE7851 dataset were downloaded from the Gene Expression
Omnibus [16].
For probe set and meta probe set level investigations, ie. the
genome-wide and regional investigations, cel files were pre-
processed using Robust Multichip Average (RMA) [17] normal-
ization as implemented in the Affymetrix Power Tools 1.8.6
package apt-probeset-summarize. Using HG-U133 plus 2.0 arrays
all probe sets were included, but when using Exon 1.0 ST arrays
the investigation was limited to the core subset of well-validated
meta probe sets, in the genome-wide scan. In the regional scan, the
full set of meta probe sets was used.
Local investigations of the MTAP, CDKN2A, CDKN2B and
ANRIL genes were done using the GeneRegionScan package [14]
from the Bioconductor repository [18] to extract probe level data
and de novo annotate each probe to its location along the length of
the gene.
Statistics
P-values are presented as unmodified p-values, however
multiple testing corrections were performed as stated in the text
using the qvalue package [19], using a false discovery rate cut-off
of 0.05.
The triplicates of GSE9372 were treated as individual data
points, because they represent different biological growths of each
cell line. Parallel investigations were made with the data
summarised per individual using the mean values, but results
where similar (data not shown).
9p21 CAD SNP & Gene Expression
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Genotypes for the GSE9372 and GSE7851 data sets were
obtained from the HapMap project webpage [15]. For ASAP and
BIKE, genomic DNA was isolated from peripheral blood
leukocytes using the QIAampH DNA Mini Kit (Qiagen,
Germany). Genotypes were measured using a TaqMan Allelic
discrimination method (Perkin Elmer Biosystems, Foster city, CA,
USA). In the ASAP data set, only the rs2891168 was measured. In
the BiKE data set the additional SNPs rs2383207, rs2383206,
rs1333049, rs1333045, rs10757278, rs10757274, and rs10116277
were genotyped in order to investigate the two main complemen-
tary CAD-risk haplotypes.
Supporting Information
File S1 Detailed local analysis in GSE9372 data set Top half of
plot shows expression level of individual microarray probes as a
function of location on gene. The four genes ANRIL, CDKN2A,
CDKN2B and MTAP are analysed. Triplets of dots indicate
median values of samples that are AA, AG and GG respectively.
Bottom half of plot shows Pearson correlation between all pairwise
combinations of probes analysed.
Found at: doi:10.1371/journal.pone.0007677.s001 (0.33 MB
PDF)
File S2 Detailed local analysis in GSE7851 data set Top half of
plot shows expression level of individual microarray probes as a
function of location on gene. The four genes ANRIL, CDKN2A,
CDKN2B and MTAP are analysed. Triplets of dots indicate
median values of samples that are AA, AG and GG respectively.
Bottom half of plot shows Pearson correlation between all pairwise
combinations of probes analysed.
Found at: doi:10.1371/journal.pone.0007677.s002 (0.38 MB
PDF)
File S3 Detailed local analysis in BiKE data set Top half of plot
shows expression level of individual microarray probes as a
function of location on gene. The four genes ANRIL, CDKN2A,
CDKN2B and MTAP are analysed. Triplets of dots indicate
median values of samples that are AA, AG and GG respectively.
Bottom half of plot shows Pearson correlation between all pairwise
combinations of probes analysed.
Found at: doi:10.1371/journal.pone.0007677.s003 (0.29 MB
PDF)
File S4 Detailed local analysis in ASAP MMed data set Top half
of plot shows expression level of individual microarray probes as a
function of location on gene. The four genes ANRIL, CDKN2A,
CDKN2B and MTAP are analysed. Triplets of dots indicate
median values of samples that are AA, AG and GG respectively.
Bottom half of plot shows Pearson correlation between all pairwise
combinations of probes analysed.
Found at: doi:10.1371/journal.pone.0007677.s004 (0.42 MB
PDF)
File S5 Detailed local analysis in ASAP AMed data set Top half
of plot shows expression level of individual microarray probes as a
function of location on gene. The four genes ANRIL, CDKN2A,
CDKN2B and MTAP are analysed. Triplets of dots indicate
median values of samples that are AA, AG and GG respectively.
Bottom half of plot shows Pearson correlation between all pairwise
combinations of probes analysed.
Found at: doi:10.1371/journal.pone.0007677.s005 (0.45 MB
PDF)
File S6 Analysis of coexpression in 8 MB region around
rs2891168 Pearson correlation between all pairwise combinations
of genes in a 8 MB region. All genes found in the full subset of
affymetrix meta probe sets were analysed, but only genes with a
genesymbol are shown here for clarity. This produces an all most
similar plot, because the more putative genes show little
correlation.
Found at: doi:10.1371/journal.pone.0007677.s006 (0.20 MB
PDF)
Author Contributions
Conceived and designed the experiments: AH HW AFC AG PE.
Performed the experiments: TK. Analyzed the data: LF TK AG JP AM
PE. Contributed reagents/materials/analysis tools: GPB AFC AG PE.
Wrote the paper: LF TK. Contributed equally as first author: TK.
References
1. The Wellcome Trust Case Control Consortium (2007) Genome-wide association
study of 14,000 cases of seven common diseases and 3,000 shared controls.
Nature 447: 661–678.
2. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, et al. (2007)
Genomewide association analysis of coronary artery disease. N Engl J Med 357:
443–453.
3. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, et al.
(2007) A common variant on chromosome 9p21 affects the risk of myocardial
infarction. Science 316: 1491–1493.
4. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, et al. (2007) A
common allele on chromosome 9 associated with coronary heart disease. Science
316: 1488–1491.
5. Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, et al. (2007)
Susceptibility to coronary artery disease and diabetes is encoded by distinct,
tightly linked, SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet.
6. Helgadottir A, Thorleifsson G, Magnusson KP, Gretarsdottir S,
Steinthorsdottir V, et al. (2008) The same sequence variant on 9p21 associates
with myocardial infarction, abdominal aortic aneurysm and intracranial
aneurysm. Nat Genet 40: 217–224.
7. Liu Y, Sanoff HK, Cho H, Burd CE, Torrice C, et al. (2009) INK4/ARF
transcript expression is associated with chromosome 9p21 variants linked to
atherosclerosis. PLoS ONE 4: e5027.
8. Jarinova O, Stewart AF, Roberts R, Wells G, Lau P, et al. (2009) Functional
Analysis of the Chromosome 9p21.3 Coronary Artery Disease Risk Locus.
Arterioscler Thromb Vasc Biol.
9. Pasmant E, Laurendeau I, Heron D, Vidaud M, Vidaud D, et al. (2007)
Characterization of a germ-line deletion, including the entire INK4/ARF locus,
in a melanoma-neural system tumor family: identification of ANRIL, an
antisense noncoding RNA whose expression coclusters with ARF. Cancer Res
67: 3963–3969.
10. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, et al. (2002) The
human genome browser at UCSC. Genome Res 12: 996–1006.
11. Kwan T, Benovoy D, Dias C, Gurd S, Provencher C, et al. (2008) Genome-wide
analysis of transcript isoform variation in humans. Nat Genet 40: 225–231.
12. Zhang W, Duan S, Kistner EO, Bleibel WK, Huang RS, et al. (2008) Evaluation
of genetic variation contributing to differences in gene expression between
populations. Am J Hum Genet 82: 631–640.
13. HapMap (2003) The International HapMap Project. Nature 426: 789–796.
14. Folkersen L, Diez D, Wheelock CE, Haeggstro ¨m JZ, Goto S, et al. (2009)
GeneRegionScan: a Bioconductor package for probe level analysis of specific,
small regions of the genome. Bioinformatics.
15. Benovoy D, Kwan T, Majewski J (2008) Effect of polymorphisms within probe-
target sequences on olignonucleotide microarray experiments. Nucleic Acids Res
36: 4417–4423.
16. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI
gene expression and hybridization array data repository. Nucleic Acids Res 30:
207–210.
17. Bolstad BM, Irizarry RA, Astrand M (2003) A comparison of normalization
methods for high density oligonucleotide array data based on variance and bias.
Bioinformatics 19: 185–193.
18. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004)
Bioconductor: open software development for computational biology and
bioinformatics. Genome Biol 5: R80.
19. Dabney A, Storey JD (2009) qvalue: Q-value estimation for false discovery rate
control. Bioconductor.
9p21 CAD SNP & Gene Expression
PLoS ONE | www.plosone.org 6 November 2009 | Volume 4 | Issue 11 | e7677